Myrobalan's experimental therapy MRO-002 is a GPR17 antagonist that's made to promote myelin repair in people with MS and ...
It causes demyelination, where the immune system attacks the myelin sheath, a protective layer of fat around brain and spinal cord nerve cells. This prevents the nerves from sending impulses or ...
EBV antibodies trigger MS by attacking brain proteins. Genetic factors worsen risk. Breakthrough insights for treatment.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback